December 2019 Distinctiions

December 2019 Distinctions


Richard Donatelli, M.D., an assistant professor in orthodontics, has been appointed program director for the Orthodontics Residency Program. His duties will include directing all aspects of orthodontics advanced education, including compliance with Commission on Dental Accreditation standards, developing
and implementing curriculum, evaluating resident performance and clinical outcomes.

Marcelle Nascimento, D.D.S., M.S., Ph.D., an associate professor in restorative dental sciences, has been appointed program director of the Dental Clinical Research Unit, or DCRU. She will be responsible for managing the DCRU and assisting colleagues with developing clinical research protocols and preparing Institutional Review Board applications. She will also ensure clinical research projects are compliant with regulations and protocols.


Larisa Cavallari, Pharm.D., BCPS, FCCP, an associate professor of pharmacotherapy and translational research, has been elected to a three-year term on the American College of Clinical Pharmacy Board of Regents. The 11-member board is responsible for setting policies and establishing procedures for ACCP and developing the strategic plan. Cavallari has been a member of ACCP since 1997 and served as a trustee and chair of ACCP’s Research Institute from 2013-16.

Guenther Hochhaus, Ph.D., a professor of pharmaceutics, has received the American College of Clinical Pharmacology’s 2019 Bristol-Myers Squibb Mentorship in Clinical Pharmacology Award. The award is given annually to a mentor who demonstrates exemplary promotion of clinical pharmacology, with an emphasis on training junior scientists or colleagues. Hochhaus joined the college in 1987, and during his tenure at UF he has published more than 200 papers and mentored more than 100 graduate students, interns and postdocs.

Julie Johnson, Pharm.D., dean and distinguished professor, was chosen for the 2019 American  College of Clinical Pharmacology Distinguished Investigator Award. The honor recognizes superior scientific expertise and accomplishments by a senior investigator in a distinct area of research in basic or clinical pharmacology. Johnson’s research focuses on cardiovascular pharmacogenomics and genomic medicine implementation.


Michael Dark, D.V.M., Ph.D., a clinical associate professor of anatomic pathology, has been named executive director of the UF Veterinary Diagnostic Laboratory. His new duties will include ensuring lab compliance with the accreditation requirements of the American Association of Veterinary Diagnosticians, as well as facilitating development of new services and methodologies.